Current diagnostic strategies include the study of families or individuals with familial aggregation and/or early onset of Lynch syndrome-associated tumors; the so-called universal MMR deficiency testing, which implies that all patients with CRC undergo tumor IHC of MMR proteins and/or MSI testing. Here, MRC1 is linked to mismatch repair cancer syndrome 1.